$Unique_ID{BRK03881} $Pretitle{} $Title{Irritable Bowel Syndrome} $Subject{Irritable Bowel Syndrome Mucous Colitis Spastic Colon Adaptive Colitis Irritable Colon Syndrome Unstable Colon Colonic Neurosis IBS } $Volume{} $Log{} Copyright (C) 1986, 1988, 1990 National Organization for Rare Disorders, Inc. 88: Irritable Bowel Syndrome ** IMPORTANT ** It is possible that the main title of the article (Irritable Bowel Syndrome) is not the name you expected. Please check the SYNONYM listing to find alternate names and disorder subdivisions covered by this article. Synonyms Mucous Colitis Spastic Colon Adaptive Colitis Irritable Colon Syndrome Unstable Colon Colonic Neurosis IBS General Discussion ** REMINDER ** The information contained in the Rare Disease Database is provided for educational purposes only. It should not be used for diagnostic or treatment purposes. If you wish to obtain more information about this disorder, please contact your personal physician and/or the agencies listed in the "Resources" section of this report. The Irritable Bowel Syndrome, commonly called Spastic Colon or Mucous Colitis, is a motility disorder which involves both the small intestine and the large bowel. It is characterized by varying degrees of abdominal pain, constipation, diarrhea, and an apparent reaction to stress in susceptible individuals. About fifty percent of all gastrointestinal problems are represented by this syndrome. Symptoms Symptoms of the Irritable Bowel Syndrome include abdominal distress, erratic frequency of bowel function, variation in the consistency of stools, bloating, nausea, headache, fatigue, lassitude and flatulence may result in disagreeable abdominal sensations. This disorder is divided into two major clinical types or groups. The spastic colon type of the syndrome is characterized by variable bowel movements. Most patients experience pain over one or more areas of the colon which is associated with periodic constipation or diarrhea. Lower abdominal pain or discomfort in the area of the sigmoid colon is a complaint of many of these patients. The pain may be colicky or a continuous dull ache may be present. The symptoms of the spastic colon type of the Irritable Bowel Syndrome may be exacerbated by ingesting food. Either constipation or diarrhea may occur; some patients experience alternate bouts of both. Common nonspecific symptoms include fatigue, depression, and anxiety. Painless diarrhea is another type of the syndrome. This group of patients may experience an urgent, precipitous diarrhea immediately upon arising. More typically, the diarrhea occurs during or immediately after a meal. Fecal incontinence may possibly occur. Nighttime diarrhea is uncommon. There does not appear to be evidence of organic disease in patients with either variant of the this syndrome and they are generally in good physical health. Causes The Irritable Bowel Syndrome has no anatomic cause. Attacks of the disorder may coincide with periods of emotional stress and conflicts. A heightened sensitivity to increased GI motility may be precipitated or aggravated by diet, certain drugs, or hormones. Affected Population The phenomenon known as the Irritable Bowel Syndrome accounts for approximately 50% of all gastrointestinal illnesses. It is especially prevalent in women between the ages of fifteen and forty-five years. The disease affects women about three times more often than men. Therapies: Standard The patient with the Irritable Bowel Syndrome needs to be reassured there is no organic disease present. Regular physical activity may help to relieve anxiety and is also important in assisting bowel function. Generally a normal diet can be followed; if flatulence is a problem, food containing fermentable carbohydrates such as beans and cabbage should be eliminated. Laxatives should be avoided if possible. Patients who suffer from spastic constipation may find the use of unprocessed bran helpful. Drug therapy may include the use of anticholinergic agents, mild tranquilizers or sedatives, and medication to relieve diarrhea. Studies are being conducted in the use of Sandoglobulin as a treatment for Irritable Syndrome. Further investigation is needed to determine it's safety and effectiveness. Therapies: Investigational This disease entry is based upon medical information available through March 1990. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder. Resources For more information on Ulcerative Colitis, please contact: National Organization for Rare Disorders (NORD) P.O. Box 8923 New Fairfield, CT 06812-1783 (203) 746-6518 National Foundation of Ileitis and Colitis, Inc. National Headquarters 295 Madison Ave., Suite 519 New York, NY 10017 (212) 685-3440 National Digestive Diseases Information Clearinghouse Box NDIC Bethesda, MD 20892 (301) 468-2162 References CECIL TEXTBOOK OF MEDICINE, 18th ed.: James B. Wyngaarden, and Lloyd H. Smith, Jr., Eds.: W. B. Saunders Co., 1988. Pp. 656-61, 722-3. THE MERCK MANUAL 15th ed: R. Berkow, et al: eds; Merck, Sharp & Dohme Research Laboratories, 1987. Pp. 808.